Pro: Methylene blue as a rescue therapy for vasoplegia after cardiac surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 25, Issue 4, 2011, Pages 736-738

  Riha, Hynek ^a   Augoustides, John G T ^b  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

amiodarone; angiotensin; calcium channel blockers; cardiopulmonary bypass; catecholamines; heparin; methylene blue; nitric oxide; nitric oxide synthase; norepinephrine; perioperative outcome; systemic vascular resistance; vasoplegia; vasopressin; blockers

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; HEPARIN; METHYLENE BLUE; NITRIC OXIDE SYNTHASE; NORADRENALIN; PHENYLEPHRINE; TERLIPRESSIN; VASOPRESSIN;

APOPTOSIS; ARTICLE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR RISK; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; HEART ASSIST DEVICE; HIGH RISK PATIENT; HUMAN; INCIDENCE; LOW DRUG DOSE; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; OFF PUMP CORONARY SURGERY; PATHOGENESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PULSE OXIMETRY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SURGICAL RISK; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION; VASOPLEGIA;

EID: 80052705291     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2011.04.005     Document Type: Note

References (51)

1. G. Shanmugam Vasoplegic syndromeThe role of methylene blue Eur J Cardiothorac Surg 28 2005 705 710 (Pubitemid 41539325)
2. W.J. Gomes, A.C. Carvalho, and J.H. Palma Vasoplegic syndrome: a new dilemma J Thorac Cardiovasc Surg 107 1994 942 943
3. R.L. Levin, M.A. Degrange, and G.F. Bruno Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery Ann Thorac Surg 77 2004 496 499 (Pubitemid 38186498)
4. M. Argenziano, J.M. Chen, and A.F. Choudhri Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent J Thorac Cardiovasc Surg 116 1998 973 980 (Pubitemid 28553541)
5. S.G. Raja, and G.D. Dreyfus Vasoplegic syndrome after off-pump coronary artery bypass surgery: An unusual complication Tex Heart Inst J 31 2004 421 424 (Pubitemid 39627880)
6. W.J. Gomes, M.R. Erlichman, and M.L. Batista-Filho Vasoplegic syndrome after off-pump coronary artery bypass surgery Eur J Cardiothorac Surg 23 2003 165 169 (Pubitemid 36143776)
7. J. Tatoulis, S. Rice, and P. Davis Patterns of postoperative systemic vascular resistance in a randomized trial of conventional on-pump versus off-pump coronary artery bypass graft surgery Ann Thorac Surg 82 2006 1436 1444 (Pubitemid 44402323)
8. X. Sun, L. Zhang, and P.C. Hill Is incidence of postoperative vasoplegic syndrome different between off-pump and on-pump coronary artery bypass grafting surgery? Eur J Cardiothorac Surg 34 2008 820 825
9. G.W. Fischer, and M.A. Levin Vasoplegia during cardiac surgery: Current concepts and management Semin Thorac Cardiovasc Surg 22 2010 140 144
10. J.H. Levy, and K.A. Tanaka Inflammatory response to cardiopulmonary bypass Ann Thorac Surg 75 2003 S715 S720 (Pubitemid 36184553)
11. N. Matsuda, and Y. Hattori Vascular biology in sepsis: Pathophysiological and therapeutic significance of vascular dysfunction J Smooth Muscle Res 43 2007 117 137
12. B. Levy, S. Collin, and N. Sennoun Vascular hyporesponsiveness to vasopressors in septic shock: From bench to bedside Intensive Care Med 36 2010 2019 2029
13. A. Mekontso-Dessap, R. Houel, and C. Soustelle Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function Ann Thorac Surg 71 2001 1428 1432
14. E. Ozal, E. Kuralay, and V. Yildirim Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery Ann Thorac Surg 79 2005 1615 1619 (Pubitemid 40614576)
15. M.A. Levin, H.M. Lin, and J.G. Castillo Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome Circulation 120 2009 1664 1671
16. P.R.B. Evora, P.J.F. Ribeiro, and W.V.A. Vicente Methylene blue for vasoplegic syndrome treatment in heart surgery: Fifteen years of questions, answers, doubts, and certainties Rev Bras Cir Cardiovasc 24 2009 279 288
17. J.G. Byrne, M. Leacche, and S. Paul Risk factors aand outcomes for vasoplegia syndrome following cardiac transplantation Eur J Cardiothorac Surg 25 2004 327 332 (Pubitemid 38340565)
18. A. Munoz, P. Karila, and P. Gallay A randomized hemodynamic comparison of intravenous amuiodarone with and without Tween 80 Eur Heart J 9 1988 142 148
19. T. Carrel, L. Englberger, and P. Mohacsi Low systemic vascular resistance after cardiopulmonary bypass: Incidence, etiology and clinical importance J Cardiovasc Surg 15 1990 347 353
20. W.J. Gomes, M.R. Erlichman, and M.L. Batista-Filho Vasoplegic syndrome after open heart surgery J Cardiovasc Surg (Torino) 39 1998 619 623 (Pubitemid 28526021)
21. M. Egi, R. Bellomo, and C. Langenberg Selecting a vasopressor drug for vasoplegic shock after adult cardiac surgery: A systematic literature review Ann Thorac Surg 83 2007 715 723 (Pubitemid 46138053)
22. S.G. Raja, and N. Fida Should angiotensin converting enzyme inhibitors/angiotensin II receptor anragonists be omitted before cardiac suregry to avoid postoperative vasodilation? Interact Cardiovasc Thorac Surg 7 2008 470 476
23. A. Miceli, R. Capoun, and C. Fino Effects of angiotensin-converting enzyme inhibitor therapy on clincial outcome in patients undergoing coronary artery bypass grafting J Am Coll Cardiol 54 2009 1778 1784
24. J.G. Augoustides Should all antihypertensives be continued before surgery? L.A. Fleisher, Evidence-Based Practice of Anesthesiology (ed 2) 2009 49 54 Philadelphia, PA
25. D.L. Morales, M.J. Garrido, and J.D. Madigan A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass Ann Thorac Surg 75 2003 926 930 (Pubitemid 36298370)
26. S. Hasija, N. Makhija, and M. Choudhury Prophylactic vasopressin in patients receiving the angiotensin-coverting enzyme inhibitoe ramipril undergoing coronary artery bypass graft surgery J Cardiothorac Vasc Anesth 24 2010 230 238
27. G. Papadopoulos, E. Sintou, and S. Siminelakis Perioperative infusion of low-dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting: A double-blind randomized study J Cardiothorac Surg 28 2010 17
28. N.F. Holt, and K.L. Haspel Vasopressin: A review of therapeutic applications J Cardiothorac Vasc Anesth 24 2010 330 347
29. A. Noto, S. Lentini, and A. Versaci A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery Interact Cardiovasc Thorac Surg 9 2009 588 592
30. J. Kunstyr, D. Lincova, and M. Mourad A retrospective analysis of terlipressin infusion in patients with refractory hypotension after cardiac surgery J Cardiovasc Surg (Torino) 49 2008 381 387 (Pubitemid 351943797)
31. E.G. Leite, A. Ronald, and A.J. Rodrigues Is methylene blue of benefit in treating adult patients who develop catecholamine-resistant vasoplegic syndrome during cardiac surgery? Interact Cardiovasc Thorac Surg 5 2006 774 778 (Pubitemid 44901245)
32. S. Moncada, R.M. Palmer, and E.A. Higgs Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol Rev 43 1991 109 142
33. B. Mayer, F. Brunner, and K. Schmidt Novel actions of methylene blue Eur Heart J 14 suppl 1 1993 22 26 (Pubitemid 23362589)
34. J. Clifton, and J.B. Leikin Methylene blue Am J Ther 10 2003 289 291
35. D. Beasley, and M. McGuiggin Interleukin I activates soluble guanylate cyclase in human vascualr smooth muscle cells through a novel nitric oxide-independent pathway J Exp Med 179 1992 71 80 (Pubitemid 24012972)
36. P.S. Myles, C.K. Leong, and J. Currey Endogenous nitric oxide and low systemic vascular resistance after cardiopulmonary bypass J Cardiothorac Vasc Anesth 11 1997 571 574 (Pubitemid 27332934)
37. P.R. Evora, P.J. Ribeiro, and J.C. de Andrade Methylene blue administration in SIRS after cardiac operations Ann Thorac Surg 63 1997 1212 1213 (Pubitemid 27191712)
38. H. Riha, L. Rihova, and M. Pindak Methylene blue in the therapy of vasoplegic syndrome after cardiac surgery procedure Cas Lek Cesk 145 2006 322 324
39. R.G. Leyh, T. Kofidis, and M. Struber Methylene blue: The drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass? J Thorac Cardiovasc Surg 125 2003 1426 1431 (Pubitemid 36759245)
40. P.R. Evora, C.H. Roselino, and P.M. Schiaveto Methylene blue in anaphylactic shock Ann Emerg Med 30 1997 240
41. P.R. Evora Should methylene blue be the drug of choice to treat vasoplegia caused by cardiopulmonary bypass and anaphylactic shock? J Thorac Cardiovasc Surg 119 2000 632 634 (Pubitemid 30146550)
42. M. Grayling, and C.D. Deakin Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis J Thorac Cardiovasc Surg 125 2003 426 427 (Pubitemid 36228329)
43. D. Sparicio, G. Landoni, and F. Pappalardo Methylene blue for lithium-induced refractory hypotension in off-pump coronary artery bypass graft: Report of two cases J Thorac Cardiovasc Surg 127 2004 592 593 (Pubitemid 38176675)
44. G.W. Fischer, and M.A. Levin Vasoplegia during cardiac surgery: Current concepts and management Semin Thorac Cardiovasc Surg 22 2010 140 144
45. D.M. Scott, and M.G. Cooper Spurious pulse oximetry with intrauterine methylene blue injection Anaesthesiol Intensiv Care 19 1991 267 268
46. L. Vutskits, A. Briner, and P. Klauser Adverse effects of methylene blue on the central nervous system Anesthesiology 108 2008 684 692 (Pubitemid 351440590)
47. A.D. Maslow, G. Stearns, and P. Butala The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass Anesth Analg 103 2006 2 8 (Pubitemid 44036021)
48. D. Lavigne Vasopressin and methylene blue: Alternate therpaies in vasodilatory shock Semin Cardiothorac Vasc Anesth 14 2010 186 189
49. A. Amin Nasr, J. Fatani, and I. Kashkari Use of methylene blue in pheochromocytoma resection: Case report Paediatr Anaesth 19 2009 396 401
50. Z. Cao, Y. Gao, and G. Tao Vasoplaegic syndrome during liver transplantation Anesth Analg 108 2009 1941 1943
51. G.W. Fischer, Y. Bengtsson, and S. Scarola Methylene blue for vasopressor-resistant vasoplegia syndrome during liver transplantation J Cardiothorac Vasc Anesth 24 2010 463 466